Biotechnology Axsome Therapeutics Supports the National Alliance on Mental Illness (NAMI) to Recognize Mental Health Awareness Month May 16, 2022
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Axsome Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – AXSM May 15, 2022
Biotechnology Pomerantz Law Firm Announces the Filing of a Class Action Against Axsome Therapeutics, Inc. and Certain Officers – AXSM May 13, 2022
Biotechnology FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of FibroGen, Inc. – FGEN May 13, 2022
Biotechnology Shareholder Alert – The M&A Class Action Firm Announces an Investigation of BioHaven Pharmaceutical Holding Company Ltd. – BHVN May 13, 2022
Biotechnology The Zacks Analyst Blog Highlights Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven Pharmaceutical May 13, 2022
Search
Biotechnology
May 15, 2022
